Lupin has informed that it has enclosed press release titled ‘Lupin Launches Penicillamine Tablets USP’, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.